4//SEC Filing
Unninayar Kamalam 4
Accession 0001209191-17-061004
CIK 0001373707other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:27 PM ET
Size
5.5 KB
Accession
0001209191-17-061004
Insider Transaction Report
Form 4
Unninayar Kamalam
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-11-15+190,000→ 190,000 totalExercise: $6.07Exp: 2027-11-14→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]This option vests over four years. Twenty-five percent (25%) of the shares will vest on November 15, 2018 and 6.25% of the shares will vest at the end of each successive three month period thereafter.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeother
Related Parties
1- filerCIK 0001720065
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 7:27 PM ET
- Size
- 5.5 KB